Physician profile
Warren D Yu
NPI 1437125564
$2,465,636.52
in general payments reported to CMS, 2019-2025
61 companies · $371K in 2025
The $371K reported for 2025 was more than what 98% of Orthopaedic Surgery of The Spine providers received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $295K · 2020: $271K · 2021: $338K · 2022: $411K · 2023: $384K · 2024: $394K · 2025: $371K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $1.0M · Consulting Fee: $64K · Travel and Lodging: $36K · Food and Beverage: $31K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,800.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $1,014,469.80 |
| Consulting Fee | $63,520.62 |
| Travel and Lodging | $35,741.19 |
| Food and Beverage | $30,822.03 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,800.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spineart Sa | $731,725.55 | 2019-2025 | Perla Tl - Degenerative Screw, Baguera-C |
| Orthofix Medical, INC. | $422,531.19 | 2019-2025 | Mariner, Physio-Stim, Cervical-Stim |
| Seaspine Orthopedics Corporation | $335,612.80 | 2019-2022 | |
| Globus Medical, INC. | $303,854.03 | 2019-2025 | Independence Mis, Independence, Independence |
| Integrity Implants INC. | $253,706.39 | 2019-2022 | Flarehawk, Linesider |
| Spineart USA INC | $120,633.83 | 2019-2025 | Perla C, Perla Tl, Bone Substitute |
| Integrity Implants INC. Dba Accelus | $120,163.38 | 2023-2024 | Flarehawk, Linesider |
| Stability Biologics, LLC | $84,529.35 | 2019-2025 | |
| Abbott Laboratories | $16,247.24 | 2019-2025 | Proclaim, Eterna, Penta |
| Xtant Medical INC | $11,772.44 | 2024 | |
| Surgalign Spine Technologies, INC. | $9,001.94 | 2019-2022 | |
| Medtronic, INC. | $8,631.01 | 2021-2025 | Intellis Adaptivestim, Cd Horizon Spinal System, Synchromedii |
| Choice Spine, LLC | $6,114.43 | 2019-2023 | Deformity Screw, Lancer Pedicle Screw System |
| Xenco Medical LLC | $5,181.55 | 2020-2021 | |
| Si-Bone, INC. | $4,255.80 | 2019-2025 |
Show all 61 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $3,963.44 | 2019-2023 | Senza |
| Alphatec Spine, INC | $2,808.36 | 2022-2024 | Other - Miscellaneous, Biologics, Invictus Mis |
| Providence Medical Technology, INC. | $2,461.41 | 2019-2025 | |
| Spineology INC. | $1,935.29 | 2022-2025 | Optimesh Expandable Interbody Fusion System |
| Zimmer Biomet Holdings, INC. | $1,897.14 | 2019-2020 | |
| Medtronic USA, INC. | $1,671.00 | 2019-2020 | |
| Boston Scientific Corporation | $1,616.35 | 2021-2025 | Wavewriter Alpha Prime 16, Infinion 16, General - Pain Management |
| Baxter Healthcare | $1,542.65 | 2022-2025 | Floseal, Actifuse |
| Cerapedics INC. | $1,465.19 | 2019-2023 | I-Factor Peptide Enhanced Bone Graft |
| Vertos Medical, INC. | $1,227.87 | 2020-2024 | Mild Device Kit |
| Arteriocyte Medical Systems, INC. | $1,126.55 | 2023-2025 | Magellan |
| Centinel Spine, LLC | $986.84 | 2021-2022 | |
| Supreme Orthopedic Systems, LLC | $892.37 | 2023-2024 | |
| Stryker Corporation | $762.35 | 2019-2022 | |
| Medical Device Business Services, INC. | $740.00 | 2023 | |
| 4web, INC. | $731.53 | 2020-2022 | |
| Depuy Synthes Sales INC. | $653.66 | 2019-2025 | Trialtis, Fibergraft Bg Morsels, Orthovisc |
| Biocomposites INC | $569.33 | 2023-2024 | Stimulan |
| Intrinsic Therapeutics | $465.21 | 2020-2023 | Barricaid Acd (Annular Closure Device) |
| Highridge Medical LLC | $377.97 | 2025 | Vital |
| Spinal Elements, INC. | $376.68 | 2021 | |
| Theragen, INC. | $370.00 | 2025 | Actastim-S |
| Mimedx Group, INC. | $317.23 | 2025 | |
| Spine Wave, INC. | $312.92 | 2024-2025 | Spinal Implant |
| Sanara Medtech INC. | $302.75 | 2021-2022 | |
| Bioventus LLC | $287.06 | 2019-2023 | Bonescalpel |
| Mml US, INC. | $260.00 | 2024 | Reactiv8 |
| Smith+Nephew, INC. | $258.76 | 2019-2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Pico 14 |
| Kci USA, INC. | $177.07 | 2019 | |
| Organogenesis INC. | $154.85 | 2019 | |
| Arthrex, INC. | $133.04 | 2024 | Arthrex |
| Aegis Spine, INC. | $123.66 | 2020 | |
| Augmedics INC. | $118.28 | 2022 | |
| Next Science LLC | $89.73 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $78.60 | 2025 | Exparel |
| Ethicon US, LLC | $76.18 | 2022 | |
| Misonix INC | $69.70 | 2021 | |
| Moximed, INC | $65.77 | 2025 | Misha Knee System, Small, Left |
| Curonix LLC | $50.58 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Musculoskeletal Transplant Foundation INC. | $32.15 | 2021-2022 | |
| Integra Lifesciences Corporation | $25.62 | 2022 | |
| Fidia Pharma USA INC. | $25.08 | 2025 | Triluron |
| Ferring Pharmaceuticals INC. | $23.93 | 2024 | Euflexxa |
| Davol INC. | $21.31 | 2021 | |
| Innovation Technologies INC | $16.51 | 2023 | Irrisept |
| Avanos Medical | $13.62 | 2023 | On-Q* Pump and Accessories |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$414,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Warren Yu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.